SEARCH

SEARCH BY CITATION

References

  • Ceraudo E, Murail S, Tan YV, Lacapere JJ, Neumann JM, Couvineau A et al. (2008a). The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics. Mol Endocrinol 22: 147155.
  • Ceraudo E, Tan YV, Nicole P, Couvineau A, Laburthe M (2008b). The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptor. J Mol Neurosci 36: 245248.
  • Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS et al. (2007). High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318: 12581265.
  • Christopoulos A, Christopoulos G, Morfis M, Udawela M, Laburthe M, Couvineau A et al. (2003). Novel receptor partners and function of receptor activity-modifying proteins. J Biol Chem 278: 32933297.
  • Chu A, Caldwell JS, Chen YA (2010). Identification and characterization of a small molecule antagonist of human VPAC(2) receptor. Mol Pharmacol 77: 95101.
  • Chugunov AO, Simms J, Poyner DR, Dehouck Y, Rooman M, Gilis D et al. (2010). Evidence that interaction between conserved residues in transmembrane helices 2, 3, and 7 are crucial for human VPAC1 receptor activation. Mol Pharmacol 78: 394401.
  • Conklin BR, Herzmark P, Ishida S, Voyno-Yasenetskaya TA, Sun Y, Farfel Z et al. (1996). Carboxyl-terminal mutations of Gq alpha and Gs alpha that alter the fidelity of receptor activation. Mol Pharmacol 50: 885890.
  • Conner AC, Hay DL, Simms J, Howitt SG, Schindler M, Smith DM et al. (2005). A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptors. Mol Pharmacol 67: 2031.
  • Conner AC, Simms J, Conner MT, Wootten DL, Wheatley M, Poyner DR (2006). Diverse functional motifs within the three intracellular loops of the CGRP1 receptor. Biochemistry 45: 1297612985.
  • Couvineau A, Lacapere JJ, Tan YV, Rouyer-Fessard C, Nicole P, Laburthe M (2003). Identification of cytoplasmic domains of hVPAC1 receptor required for activation of adenylyl cyclase. Crucial role of two charged amino acids strictly conserved in class II G protein-coupled receptors. J Biol Chem 278: 2475924766.
  • Couvineau A, Ceraudo E, Tan YV, Laburthe M (2010). VPAC1 receptor binding site: contribution of photoaffinity labeling approach. Neuropeptides 44: 127132.
  • Cypess AM, Unson CG, Wu CR, Sakmar TP (1999). Two cytoplasmic loops of the glucagon receptor are required to elevate cAMP or intracellular calcium. J Biol Chem 274: 1945519464.
  • Dickson L, Finlayson K (2009). VPAC and PAC receptors: from ligands to function. Pharmacol Ther 121: 294316.
  • Frimurer TM, Bywater RP (1999). Structure of the integral membrane domain of the GLP1 receptor. Proteins 35: 375386.
  • Gaudin P, Maoret JJ, Couvineau A, Rouyer-Fessard C, Laburthe M (1998). Constitutive activation of the human vasoactive intestinal peptide 1 receptor, a member of the new class II family of G protein-coupled receptors. J Biol Chem 273: 49904996.
  • Gaudin P, Couvineau A, Rouyer-Fessard C, Maoret JJ, Laburthe M (1999). The human vasoactive intestinal Peptide/Pituitary adenylate cyclase activating peptide receptor 1 (VPAC1): constitutive activation by mutations at threonine 343. Biochem Biophys Res Commun 254: 1520.
  • Grace CR, Perrin MH, Gulyas J, Digruccio MR, Cantle JP, Rivier JE et al. (2007). Structure of the N-terminal domain of a type B1 G protein-coupled receptor in complex with a peptide ligand. Proc Natl Acad Sci USA 104: 48584863.
  • ter Haar E, Koth CM, Abdul-Manan N, Swenson L, Coll JT, Lippke JA et al. (2010). Crystal structure of the ectodomain complex of the CGRP receptor, a class-B GPCR, reveals the site of drug antagonism. Structure 18: 10831093.
  • Harikumar KG, Morfis MM, Lisenbee CS, Sexton PM, Miller LJ (2006). Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors. Mol Pharmacol 69: 363373.
  • Hoare SR (2005). Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today 10: 417427.
  • Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR et al. (2008). The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322: 12111217.
  • Laburthe M, Couvineau A, Tan V (2007). Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology. Peptides 28: 16311639.
  • Langer I, Robberecht P (2005). Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation. Cell Signal 17: 1724.
  • Langer I, Vertongen P, Perret J, Waelbroeck M, Robberecht P (2002). A small sequence in the third intracellular loop of the VPAC(1) receptor is responsible for its efficient coupling to the calcium effector. Mol Endocrinol 16: 10891096.
  • Langer I, Vertongen P, Perret J, Waelbroeck M, Robberecht P (2003). Lysine 195 and aspartate 196 in the first extracellular loop of the VPAC1 receptor are essential for high affinity binding of agonists but not of antagonists. Neuropharmacology 44: 125131.
  • Langer I, Gaspard N, Robberecht P (2006). Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2). Br J Pharmacol 148: 10511059.
  • Nachtergael I, Gaspard N, Langlet C, Robberecht P, Langer I (2006). Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor. Cell Signal 18: 21212130.
  • Neumann JM, Couvineau A, Murail S, Lacapere JJ, Jamin N, Laburthe M (2008). Class-B GPCR activation: is ligand helix-capping the key? Trends Biochem Sci 33: 314319.
  • Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA et al. (2000). Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289: 739745.
  • Park JH, Scheerer P, Hofmann KP, Choe HW, Ernst OP (2008). Crystal structure of the ligand-free G-protein-coupled receptor opsin. Nature 454: 183187.
  • Parthier C, Kleinschmidt M, Neumann P, Rudolph R, Manhart S, Schlenzig D et al. (2007). Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor. Proc Natl Acad Sci USA 104: 1394213947.
  • Perret J, Vertongen P, Solano RM, Langer I, Cnudde J, Robberecht P et al. (2002). Two tyrosine residues in the first transmembrane helix of the human vasoactive intestinal peptide receptors play a role in supporting the active conformation. Br J Pharmacol 136: 10421048.
  • Pioszak AA, Xu HE (2008). Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci USA 105: 50345039.
  • Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC et al. (2007). Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450: 383387.
  • Rosenbaum DM, Rasmussen SG, Kobilka BK (2009). The structure and function of G-protein-coupled receptors. Nature 459: 356363.
  • Rosenbaum DM, Zhang C, Lyons JA, Holl R, Aragao D, Arlow DH et al. (2011). Structure and function of an irreversible agonist-beta(2) adrenoceptor complex. Nature 469: 236240.
  • Runge S, Thogersen H, Madsen K, Lau J, Rudolph R (2008). Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. J Biol Chem 283: 1134011347.
  • Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, Choe HW et al. (2008). Crystal structure of opsin in its G-protein-interacting conformation. Nature 455: 497502.
  • Solano RM, Langer I, Perret J, Vertongen P, Juarranz MG, Robberecht P et al. (2001). Two basic residues of the h-VPAC1 receptor second transmembrane helix are essential for ligand binding and signal transduction. J Biol Chem 276: 10841088.
  • Sun C, Song D, Davis-Taber RA, Barrett LW, Scott VE, Richardson PL et al. (2007). Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS. Proc Natl Acad Sci USA 104: 78757880.
  • Tams JW, Knudsen SM, Fahrenkrug J (2001). Characterization of a G protein coupling ‘YL’ motif of the human VPAC1 receptor, equivalent to the first two amino acids in the ‘DRY’ motif of the rhodopsin family. J Mol Neurosci 17: 325330.
  • Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R et al. (2008). Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454: 486491.
  • Xu F, Wu H, Katritch V, Han GW, Jacobson KA, Gao ZG et al. (2011). Structure of an agonist-bound human A2A adenosine receptor. Science 332: 322327.